Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Morgan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
AIDS Research and Human Retroviruses|January 25, 2013
Issues in women's participation in a phase III community HIV vaccine trial in ThailandJaranit Kaewkungwal, Punnee Pitisuttithum, Supachai Rerks-Ngarm, et al.
Stroke|January 12, 2021
Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time WindowsRaul G Nogueira, Diogo C Haussen, David Liebeskind, et al.
The Lancet. Infectious Diseases|June 2, 2012
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144Merlin L Robb, Supachai Rerks-Ngarm, Sorachai Nitayaphan, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 16, 2021
Influence of time to endovascular stroke treatment on outcomes in the early versus extended window paradigmsRaul G Nogueira, Tudor G Jovin, Diogo C Haussen, et al.
The Journal of Infectious Diseases|July 24, 2004
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adultsSorachai Nitayaphan, Punnee Pitisuttithum, Chitraporn Karnasuta, et al.
The Journal of Infectious Diseases|May 19, 2021
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn InfantsElizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, et al.
Journal of Virology|April 12, 2013
Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trialGustavo H Kijak, Sodsai Tovanabutra, Supachai Rerks-Ngarm, et al.
Plos One|December 30, 2011
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in ThailandPunnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 11, 2021
Clinical effectiveness of endovascular stroke treatment in the early and extended time windowsRaul G Nogueira, Diogo C Haussen, David S Liebeskind, et al.
The Lancet. Infectious Diseases|May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialEmily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
AIDS Research and Human Retroviruses|January 25, 2013
Issues in women's participation in a phase III community HIV vaccine trial in ThailandJaranit Kaewkungwal, Punnee Pitisuttithum, Supachai Rerks-Ngarm, et al.
Stroke|January 12, 2021
Stroke Imaging Selection Modality and Endovascular Therapy Outcomes in the Early and Extended Time WindowsRaul G Nogueira, Diogo C Haussen, David Liebeskind, et al.
The Lancet. Infectious Diseases|June 2, 2012
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144Merlin L Robb, Supachai Rerks-Ngarm, Sorachai Nitayaphan, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 16, 2021
Influence of time to endovascular stroke treatment on outcomes in the early versus extended window paradigmsRaul G Nogueira, Tudor G Jovin, Diogo C Haussen, et al.
The Journal of Infectious Diseases|July 24, 2004
Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adultsSorachai Nitayaphan, Punnee Pitisuttithum, Chitraporn Karnasuta, et al.
The Journal of Infectious Diseases|May 19, 2021
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn InfantsElizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, et al.
Journal of Virology|April 12, 2013
Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trialGustavo H Kijak, Sodsai Tovanabutra, Supachai Rerks-Ngarm, et al.
Plos One|December 30, 2011
Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in ThailandPunnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 11, 2021
Clinical effectiveness of endovascular stroke treatment in the early and extended time windowsRaul G Nogueira, Diogo C Haussen, David S Liebeskind, et al.
The Lancet. Infectious Diseases|May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialEmily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
Pageof 3